CharmHealth, a leading provider of healthcare technology solutions, today announced that Binah.ai CEO and Founder David Maman and Divya Chander, chair of neuroscience, faculty in medicine at Singularity University, will be the keynote speakers for the 2023 Innovation Challenge. Maman and Chander will address…
The “Artificial Intelligence and Machine Learning Powered Signal Management Training Course” conference has been added to ResearchAndMarkets.com’s offering. The quest to find precise evidence to answer complex questions from biomedicine and Healthcare for Drug Safety has brought us to a major crossroads. With the…
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today commented on the issuance of proposed changes to the Local Coverage…
CAS is the American Chemical Society’s specialized division for scientific information solutions and Molecule.one is the Leading company in biotechnology. The two institutions have entered into a strategic collaboration focused on the joint development of computer-aided synthetic design techniques to accelerate…
Appili Therapeutics Inc. (TSX:APLI; OTCQB: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense products, today announced its financial and operational results for the first quarter of its fiscal year 2024, which…
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards to three new employees. The Compensation Committee of the Board of Directors of Marinus…
HDL Therapeutics, Inc. (“HDL Therapeutics”), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia (HoFH), has signed a definitive merger agreement…
Second-Quarter 2023 Revenues of $12.7 Billion– Expected Decline in Paxlovid and Comirnaty(1) Revenues Drove 53% Operational Decrease in SecondQuarter 2023 Revenues– Second-Quarter 2023 Revenues from Comirnaty(1) and Paxlovid of $1.6 Billion– Excluding Contributions from Comirnaty(1) and Paxlovid, Revenues Grew 5%…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for ERVEBO, which is now indicated for the prevention of disease caused…
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company’s capital stock, payable on September 5, 2023, to shareholders of record as of August 14, 2023. This is a 2-cent, or 5.3%, increase…
Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it has been named to Fortune’s “Global 500” for 2023, the annual ranking of the top 500 companies worldwide by total revenue. Centene first made the…
McKesson Medical-Surgical, an affiliate of the McKesson Corporation, will participate as a silver sponsor of the National Association of Community Health Centers National Health Center Week 2023 (NHCW) Aug. 6-12. The theme of NHCW 2023 is “Community Health Centers: The…